Aptamer-based detection of disease biomarkers in mouse models for chagas drug discovery.
Drug discovery initiatives, aimed at Chagas treatment, have been hampered by the lack of standardized drug screening protocols and the absence of simple pre-clinical assays to evaluate treatment efficacy in animal models. In this study, we used a simple Enzyme Linked Aptamer (ELA) assay to detect T....
Main Authors: | Fernanda Fortes de Araujo, Rana Nagarkatti, Charu Gupta, Ana Paula Marino, Alain Debrabant |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4287562?pdf=render |
Similar Items
-
Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice.
by: Rana Nagarkatti, et al.
Published: (2014-01-01) -
Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in blood.
by: Rana Nagarkatti, et al.
Published: (2012-01-01) -
Using Aptamers for Cancer Biomarker Discovery
by: Yun Min Chang, et al.
Published: (2013-01-01) -
Advances in Aptamer-Based Biomarker Discovery
by: Jie Huang, et al.
Published: (2021-03-01) -
Aptamer-based multiplexed proteomic technology for biomarker discovery.
by: Larry Gold, et al.
Published: (2010-12-01)